RAMMRAMM Pharma Corp.

CNQ · CA · Healthcare · Drug Manufacturers - Specialty & Generic · wearerammpharma.com

0.0100CADMkt Cap: 869466 $P/E: —25d ago

RAMM Pharma Corp., together with its subsidiaries, operates in the pharmaceutical and medical product business in Uruguay and Poland. The company offers cannabinoid pharmacology and product formulation for cannabis-based…

Industry Peers

Drug Manufacturers - Specialty & Generic

Screen all

MRK

MERCK Kommanditgesellschaft auf Aktien

$65.19BUSDP/E 23.7

TAK

Takeda Pharmaceutical Co. Ltd.

$58.06BUSD

HLN

Haleon plc American Depositary Shares (Each representing two Ordinary Shares)

$43.98BUSDP/E 20.4

TEVA

Teva Pharmaceutical Industries Limited

United Therapeutics Corporation

Swedish Orphan Biovitrum AB

Neurocrine Biosciences, Inc.

$15.51BUSDP/E 22.3

ELAN

Elanco Animal Health Incorporat

$11.98BUSD

RDY

Dr. Reddy's Laboratories Ltd

Hims & Hers Health, Inc.

$7.88BUSD

LNTH

Lantheus Holdings Inc

$6.53BUSDP/E 23.9

AMRX

Amneal Pharmaceuticals, Inc. Class A

Kiniksa Pharmaceuticals, Ltd.

$6.08BUSDP/E 79.8

Key Statistics

Company

Market Cap869.47K $

Enterprise Value814.57K $

Revenue (TTM)1.38M $

Gross Profit779.73K $

Net Income (TTM)-6.49M $

Revenue/Share0.0117 USD

Last Price0.0100 CAD

Fiscal Year EndOct 2025

MR QuarterApr 2026

Employees—

CountryCA

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)—

PEG—

EV/EBITDA-0.29

EV/Revenue0.59

P/S0.63

P/B0.28

EPS (TTM)-0.07

EPS (Forward)—

52W Range

—

52W High0.0100 CAD

52W Low0.0100 CAD

Profitability

Gross Margin31.86%

Oper. Margin-433.96%

EBITDA Margin-206.18%

Profit Margin-265.13%

ROE-156.37%

ROA-96.12%

Growth

Revenue Growth-77.90%

Earnings Growth—

Cash Flow & Leverage

Operating CF-771.93K $

CapEx (TTM)—

FCF Margin5.97%

FCF Yield9.46%

Net Debt-54.89K $

Net Debt/EBITDA0.02

Balance Sheet

Debt/Equity0.01

Current Ratio0.47

Quick Ratio0.20

Book Value/Sh0.0360 CAD

Cash/Share0.0010 CAD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 CAD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.119.39M

Float81.87M

Insiders31.43%

Institutions0.00%

Short Interest

Short Ratio0.0d

Short % Out.0.00%

Shares Short772

Short (prev mo.)792

Technical

SMA 500.0111 (-9.9%)

SMA 2000.0250 (-60.0%)

Beta0.59

S&P 52W Chg18.16%

Avg Vol (30d)0

Avg Vol (10d)10.20K

Technical Indicators

RSI (14)44.9

MACD-0.0005

MACD Signal-0.0007

MACD Hist.+0.0002

BB Upper0.0126 CAD

BB Middle0.0095 CAD

BB Lower0.0064 CAD

BB Width64.80%

ATR (14)0.0004 CAD

Vol Ratio (20d)0.08x